https://biotechmorning.com/news/teva-bioxcel-igalmi-bankruptcy-bid Biotech Morning en 2026-08-29T14:19:05.606Z Teva's $57.5M Bargain Hunt in Biotech's Graveyard https://biotechmorning.com/news/mounjaro-cardiovascular-approval-glp1-race Biotech Morning en 2026-08-29T14:18:19.420Z Mounjaro Just Got a Promotion. Novo Nordisk Should Be Nervous. https://biotechmorning.com/news/astrazeneca-cardio-ttransform-rna-silencer-flop Biotech Morning en 2026-08-29T14:17:32.504Z The Heart Drug That Worked on Paper but Flopped Where It Counted https://biotechmorning.com/news/mimrylo-rusfertide-fda-approval-polycythemia-vera Biotech Morning en 2026-08-29T14:16:43.336Z The Drug That Could Make Blood Draws Obsolete for Thousands https://biotechmorning.com/news/cancer-vaccine-that-made-things-worse Biotech Morning en 2026-08-29T14:16:02.275Z The Cancer Vaccine That Made Things Worse https://biotechmorning.com/news/shingrix-cardiovascular-benefit-oxford-study Biotech Morning en 2026-08-29T14:14:59.743Z A Shingles Vaccine That Protects Your Heart? Oxford Says Maybe https://biotechmorning.com/news/aficamten-non-obstructive-hcm-acacia-trial Biotech Morning en 2026-08-29T14:14:14.055Z The Heart Drug That Just Crashed a Party It Wasn't Invited To https://biotechmorning.com/news/one-shot-rewrite-cholesterol-forever Biotech Morning en 2026-08-29T14:13:29.025Z One Shot to Rewrite Your Cholesterol Forever https://biotechmorning.com/news/moderna-2-6-billion-bet-mrna-cancer Biotech Morning en 2026-08-29T14:12:46.410Z Moderna Just Bet $2.6 Billion That mRNA Can Kill Cancer https://biotechmorning.com/news/covid-vaccines-annual-update-cycle-2026 Biotech Morning en 2026-08-28T14:20:22.093Z COVID Vaccines Now Update Like iPhones https://biotechmorning.com/news/tezspire-eosinophilic-esophagitis-phase-3-crossing-results Biotech Morning en 2026-08-28T14:19:36.937Z Tezspire Just Crashed Dupixent's Party in a Big Way https://biotechmorning.com/news/genentech-dualitybio-adc-resistance-billion-dollar-deal Biotech Morning en 2026-08-28T14:18:51.998Z Genentech Just Bet $1 Billion That ADCs Have an Achilles' Heel https://biotechmorning.com/news/gilead-bixlenvo-lenacapavir-oral-hiv-pill Biotech Morning en 2026-08-28T14:18:04.935Z Gilead Just Put Its Best Injectable Drug in a Tiny Pill https://biotechmorning.com/news/rasonque-pancreatic-cancer-fda-approval Biotech Morning en 2026-08-28T14:17:19.770Z The Drug That Just Rewrote Pancreatic Cancer's Worst Odds https://biotechmorning.com/news/alnylam-heart-drug-wall-street-trust-crisis Biotech Morning en 2026-08-28T14:16:34.693Z Alnylam's Heart Drug Just Hit a Wall Street Trust Crisis https://biotechmorning.com/news/white-house-midsize-biotech-drug-pricing-deals Biotech Morning en 2026-08-28T14:15:47.278Z The White House Is Coming for Midsize Biotech's Pricing Power https://biotechmorning.com/news/sk-biohaven-kv7-epilepsy-deal Biotech Morning en 2026-08-28T14:15:04.884Z The $795M Bet on a Brain Channel That Already Failed Once https://biotechmorning.com/news/hbv-cccdna-elimination-first-clinical-evidence Biotech Morning en 2026-08-28T14:14:20.221Z The Virus That Hides a Secret Copy of Itself Just Got Caught https://biotechmorning.com/news/metsera-founders-launch-sentivera-inflammation-deal Biotech Morning en 2026-08-28T14:13:31.515Z The Duo That Sold a Biotech to Pfizer Is Back With a New One https://biotechmorning.com/news/first-pill-dermatomyositis-lisraya-fda-approval Biotech Morning en 2026-08-28T14:12:44.035Z The First Pill for a Disease That's Had None